ADVANCED HEALTH LIMITED - Dealing by a director

Dealing by a director

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049        JSE Code: AVL


DEALING BY A DIRECTOR


In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the Johannesburg Stock
Exchange (“JSE”), the following information relating to a trade in the ordinary shares of the Company
by a director of the company is disclosed:

Name of director:                            Carl Alfred Grillenberger
Name of company:                             Advanced Health Limited
Date of transaction:                         22 February 2017
Number of securities:                        106 848
Class of securities:                         Ordinary shares
Nature of transaction:                       On market purchase
Price per share:                             150 cents per share
Nature of interest:                          Indirect beneficial
Extent of interest:                          Less than 0.05%
Value of transaction:                        R160 272.00
Clearance to deal obtained:                  Yes

Name of director:                            Carl Alfred Grillenberger
Name of company:                             Advanced Health Limited
Date of transaction:                         22 February 2017
Number of securities:                        14 967
Class of securities:                         Ordinary shares
Nature of transaction:                       On market purchase
Price per share:                             149 cents per share
Nature of interest:                          Indirect beneficial
Extent of interest:                          Less than 0.01%
Value of transaction:                        R22 300.83
Clearance to deal obtained:                  Yes

Name of director:                            Carl Alfred Grillenberger
Name of company:                             Advanced Health Limited
Date of transaction:                         22 February 2017
Number of securities:                        30 506
Class of securities:                         Ordinary shares
Nature of transaction:                       On market purchase
Price per share:                             148 cents per share
Nature of interest:                          Indirect beneficial
Extent of interest:                          Less than 0.01%
Value of transaction:                        R45 148.88
Clearance to deal obtained:                  Yes

Name of director:                            Carl Alfred Grillenberger
Name of company:                             Advanced Health Limited
Date of transaction:                         22 February 2017
Number of securities:                        36 000
Class of securities:                         Ordinary shares
Nature of transaction:                       On market purchase
Price per share:                             145 cents per share
Nature of interest:                          Indirect beneficial
Extent of interest:                          Less than 0.01%
Value of transaction:                        R52 200
Clearance to deal obtained:                  Yes

Name of director:                            Carl Alfred Grillenberger
Name of company:                             Advanced Health Limited
Date of transaction:                         22 February 2017
Number of securities:                        20 000
Class of securities:                         Ordinary shares
Nature of transaction:                       On market purchase
Price per share:                             140 cents per share
Nature of interest:                          Indirect beneficial
Extent of interest:                          Less than 0.01%
Value of transaction:                        R28 000
Clearance to deal obtained:                  Yes



Johannesburg
24 February 2017

Designated Advisor
Grindrod Bank Limited

Date: 24/02/2017 09:15:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.